XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Class A
Common Class B
Ordinary shares
Common Class A
Ordinary shares
Common Class A
Restricted Stock Units (RSUs)
Ordinary shares
Common Class B
Treasury Stock [Member]
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021       373,455,485   76,179,938        
Beginning balance at Dec. 31, 2021 $ 866,261     $ 37   $ 8   $ 1,099,369 $ 3,149 $ (236,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted shares and RSUs 901     $ 1       900    
Vesting of restricted shares and RSUs (in shares)         2,330,328          
Share-based compensation expense (Note 18) 27,851             27,851    
Net Income (Loss) (120,380)                 (120,380)
Foreign currency translation adjustments (9,857)               (9,857)  
Settlement of VPP (Note 18) 5,727             5,727    
Share repurchase (Note 17) (in shares)             (35,839,004)      
Share repurchase (Note 17) (41,815)           $ (41,815)      
Unrealized gain on debt securities (1,286)               (1,286)  
Exercise of options (in shares)       10,511,776            
Exercise of options 858     $ 1       857    
Treasury shares at cost (in shares) at Dec. 31, 2022             (35,839,004)      
Ending balance (in shares) at Dec. 31, 2022       386,297,589   76,179,938        
Ending balance at Dec. 31, 2022 728,260     $ 39   $ 8 $ (41,815) 1,134,704 (7,994) (356,682)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted shares and RSUs 152           $ 9,415 (9,263)    
Vesting of restricted shares and RSUs (in shares)         3,048,212   5,469,616      
Share-based compensation expense (Note 18) 21,901             21,901    
Net Income (Loss) (87,219)                 (87,219)
Foreign currency translation adjustments (3,418)               (3,418)  
Settlement of VPP (Note 18) 3,791             3,791    
Share repurchase (Note 17) (in shares)             (77,984,836)      
Share repurchase (Note 17) (62,441)           $ (62,441)      
Unrealized gain on debt securities 1,385               1,385  
Exercise of options (in shares)       1,978,416     9,658,772      
Exercise of options 2,338           $ 15,125 (12,787)    
Treasury shares at cost (in shares) at Dec. 31, 2023             (98,695,452)      
Treasury shares at cost, value at Dec. 31, 2023 $ (79,716)                  
Ending balance (in shares) at Dec. 31, 2023 368,808,703 292,628,765 76,179,938 391,324,217   76,179,938        
Ending balance at Dec. 31, 2023 $ 604,749     $ 39   $ 8 $ (79,716) 1,138,346 (10,027) (443,901)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted shares and RSUs             $ 4,401 (4,401)    
Vesting of restricted shares and RSUs (in shares)             5,073,672      
Share-based compensation expense (Note 18) 22,397             22,397    
Net Income (Loss) (42,727)                 (42,727)
Foreign currency translation adjustments (2,230)               (2,230)  
Settlement of VPP (Note 18) 248             248    
Share repurchase (Note 17) (in shares)             (16,805,024)      
Share repurchase (Note 17) $ (10,929)           $ (10,929)      
Exercise of options (in shares) 13,773,112     1,052,000     15,207,180      
Exercise of options $ 1,153           $ 13,505 (12,352)    
Treasury shares at cost (in shares) at Dec. 31, 2024             (95,219,624)      
Treasury shares at cost, value at Dec. 31, 2024 $ (72,739)                  
Ending balance (in shares) at Dec. 31, 2024 373,336,531 297,156,593 76,179,938 392,376,217   76,179,938        
Ending balance at Dec. 31, 2024 $ 572,661     $ 39   $ 8 $ (72,739) $ 1,144,238 $ (12,257) $ (486,628)